{
    "clinical_study": {
        "@rank": "52006", 
        "arm_group": {
            "arm_group_label": "PV or ET", 
            "description": "subject who has polycythemia vera or essential thrombocythemia"
        }, 
        "biospec_descr": {
            "textblock": "CD34+ cells isolated from the peripheral blood Splenic CD34+ cells"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "The purpose of the study is to isolate and characterize stem cells of patients with\n      Polycythemia Vera (PV) and Essential Thrombocythemia (ET) to find out why these cells are\n      not working the way they should be and why they seem to be sensitive to regulatory factors\n      in the blood, such as clotting."
        }, 
        "brief_title": "Tissue Banking Study - Polycythemia Vera or Essential Thrombocythemia (PV & ET) Patients", 
        "completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Polycythemia Vera", 
            "Essential Thrombocythemia"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Myeloproliferative Disorders", 
                "Polycythemia", 
                "Polycythemia Vera", 
                "Thrombocythemia, Essential", 
                "Thrombocytosis"
            ]
        }, 
        "detailed_description": {
            "textblock": "Specific Aim 1: Assess the effects of RG7112 on MPN HSC/HPC p53 levels and study how it\n      affects MPN stem cell function.\n\n      Specific Aim 2. Assess the effects of a combination of low doses of IFN\u03b1 and RG7112 on MPN\n      HSC/HPC."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  polycythemia vera or essential thrombocythemia\n\n          -  agree to give blood for study\n\n        Exclusion Criteria:\n\n          -  none"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients who have polycythemia vera or essential thrombocythemia"
            }
        }, 
        "enrollment": {
            "#text": "400", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01970930", 
            "org_study_id": "GCO 12-0481"
        }, 
        "intervention": {
            "arm_group_label": "PV or ET", 
            "description": "4 green top tube 40 cc of blood draw", 
            "intervention_name": "Blood specimen", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Tissue banking", 
        "lastchanged_date": "October 22, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "New York", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10029"
                }, 
                "name": "Icahn School of Medicine at Mount Sinai"
            }, 
            "investigator": {
                "last_name": "Ronald Hoffman, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Treatment Strategies for Myeloproliferative Neoplasms by Targeting the Tumor Suppressor P53", 
        "overall_contact": {
            "email": "jill.kleczko@mssm.edu", 
            "last_name": "Jill Kleczko, MPA", 
            "phone": "212-241-0573"
        }, 
        "overall_contact_backup": {
            "email": "ronald.hoffman@mssm.edu", 
            "last_name": "Ronald Hoffman, MD", 
            "phone": "212-241-2296"
        }, 
        "overall_official": {
            "affiliation": "Mount Sinai School of Medicine", 
            "last_name": "Ronald Hoffman, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Assess the effects of RG7112 on MPN HSC/HPC p53 levels and study how it affects MPN stem cell function.", 
            "measure": "Stem cell function", 
            "safety_issue": "No", 
            "time_frame": "at one time study visit"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01970930"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Assess the effects of a combination of low doses of IFN\u03b1 and RG7112 on MPN HSC/HPC. After treatment with RG7112 and IFN\u03b1 at the various doses, p53, MDM2, MDMX, phosphor-p38, and phosphor-STAT1 levels in MPN CD34+ cells will be measured using monoclonal antibody staining and flow cytometric and immunofluorescence analyses.", 
            "measure": "CD34+ cells assays", 
            "safety_issue": "No", 
            "time_frame": "at one time study visit"
        }, 
        "source": "Mount Sinai School of Medicine", 
        "sponsors": {
            "collaborator": {
                "agency": "The Leukemia and Lymphoma Society", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Mount Sinai School of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "October 2013"
    }
}